Vital Farms stock falls 1.79 percent as Q2 losses widen

Published on 09/24/2026 at 18:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Vital Farms stock traded at USD 10.13 on September 24, 2026, after the prior close of USD 10.31. Q2 revenue reached USD 166 million, down 10.1 percent year over year.

Vital Farms stock, consumer defensive, Q2 2026 results, strategic options, Nasdaq, Illustration mit AI erstellt.

Vital Farms stock (ISIN US92847W1036) was trading at USD 10.13 on Nasdaq on September 24, 2026, down 1.79 percent from the prior close of USD 10.31. The decline followed a 9 percent drop on September 23 as investors reassessed reports about possible strategic options for the company, as Yahoo Finance reported.

Q2 sales fell 10.1 percent

Vital Farms reported Q2 2026 revenue of USD 166 million, a 10.1 percent year-over-year decline, while the quarter produced a net loss of USD 31.1 million. The figures show why the stock reaction is tied to operating performance as much as to takeover speculation.

The company serves the pasture-raised egg and dairy market, but Q2 profitability weakened sharply. Revenue remained above the USD 160 million analyst estimate cited by Investing.com, yet the loss profile dominated the comparison with the prior year.

Margins now drive the debate

Structured Q2 data show gross profit of USD 10.931 million and an operating loss of USD 40.146 million. Gross profit therefore represented 7 percent of revenue, while the operating margin was negative 24 percent, making cost control the central operating question for the shares.

Vital Farms sells shell eggs, butter, hard-boiled eggs, liquid whole eggs and egg bites through more than 24,000 stores, according to the company investor site. Its network also includes more than 600 family farms, giving the business national reach while leaving quarterly earnings exposed to supply and pricing conditions.

Stock stays below its yearly high

At USD 10.13 on Nasdaq on September 24, 2026, the stock was 77.58 percent below its 52-week high of USD 45.16 and 27.42 percent above its 52-week low of USD 7.95. The USD 433.87 million market capitalization places the Q2 loss and the strategic-options reports in a much smaller valuation framework than a year earlier.